Today: 12 June 2026
VOYG jumps after BTIG buy call, SpaceX IPO talk heats up
11 June 2026
2 mins read

VOYG jumps after BTIG buy call, SpaceX IPO talk heats up

New York, June 11, 2026, 15:02 ET

  • Voyager Technologies surged roughly 17% on Thursday, last seen around $48.26. The stock reached as high as $49.71 in intraday trading.
  • BTIG started coverage on VOYG with a Buy and set the price target at $55. The new view from the Street adds a fresh catalyst to the stock’s run.
  • Investor focus on commercial space names picked up as the market waited for SpaceX’s possible IPO.

Voyager Technologies, Inc. shares jumped Thursday after bullish analyst coverage and fresh interest in space and defense stocks. VOYG last changed hands at $48.26, up 16.91% at 3:02 p.m. ET. The stock opened at $43.40 and traded between $42.76 and $49.71. Google Finance showed 3.52 million shares in volume and a market cap near $2.85 billion.

BTIG Research kicked off coverage on Voyager with a Buy rating and a $55 price target, which moved the stock. MarketScreener said BTIG’s call hit at 7:18 a.m. EDT, citing MT Newswires. TipRanks/TheFly also flagged BTIG analyst Andre Madrid’s Buy rating and $55 target.

BTIG called Voyager “an increasingly scaled, acquisition-driven consolidator of critical space and missile-defense technologies” in a note covered by TipRanks/TheFly. The broker stuck with a $55 price target, which is still above where shares traded Thursday afternoon, but with the stock’s rally, the implied upside from the previous $41.28 close got smaller. TipRanks

VOYG jumped 6.4% before the bell Thursday after BTIG started coverage, Investing.com said, pointing to the company’s ties to national security funding and its propulsion tech. By the afternoon, Voyager was up much more than the market. SPY added around 1.4%, QQQ gained 2.5%, and DIA was up 1.7%.

Sector sentiment got a boost too. Reuters on Thursday pointed to a Bloomberg News report that SpaceX picked up over $70 billion in retail investor orders for its IPO. Reuters also said the company’s debut is set for Friday, aiming to raise $75 billion at about a $1.8 trillion valuation. Reuters said it couldn’t confirm the Bloomberg report on retail demand.

The SpaceX pricing window is drawing attention to peer space stocks. TipRanks said there’s renewed interest in space names around the IPO, with Voyager getting a boost. Google Finance’s related-stocks panel showed moves in Rocket Lab, Intuitive Machines and AST SpaceMobile as well.

Voyager hasn’t been public long. The company’s Class A common stock started trading on the NYSE as VOYG on June 11, 2025. It priced its IPO at $31 a share and raised about $402.3 million in net proceeds.

Voyager calls itself a defense technology and space solutions firm, with work in propulsion, energetics, advanced electronics, mission management and space exploration. The mix of defense and space is key for investors debating if VOYG gets a premium as U.S. defense budgets and commercial space infrastructure spending shift.

Voyager reported first-quarter results on May 4, showing backlog hit a record at $275.3 million, up 54% from a year earlier. Bookings for the quarter came in at $45.2 million, with a book-to-bill ratio of 1.3. Net sales for the first quarter landed at $35.2 million. The company also bumped up its 2026 revenue guidance, now targeting a range of $230 million to $255 million.

Voyager is still waiting on its Astrobotic Technology deal. The company said on June 2 it will buy Astrobotic for as much as $300 million in cash and stock, including some contingent consideration. Voyager expects the deal to close by early July 2026, if it gets regulatory signoff. “This would make Voyager a lunar platform,” chairman and CEO Dylan Taylor said, linking the tie-up to future Moon infrastructure. MarketScreener

VOYG didn’t reach its 52-week high of $63.88, even after Thursday’s rally, but the stock is still trading well above its 52-week low of $17.41. Analyst sentiment on Google Finance is mostly Buy, with seven Buy ratings, one Hold, and one Sell. The average 12-month target is $45.33, lower than Thursday afternoon’s price. VOYG is still relying on deal momentum and the defense sector trade.

Stock Market Today

  • Stocks Surge on Iran Peace Hopes, Oil Prices Drop
    June 11, 2026, 5:57 PM EDT. Stocks rallied to their best day in two months as President Trump called off threats to bomb Iran, raising hopes for a deal to resume global oil flows. The S&P 500 jumped 1.8%, Dow rose 1.9%, and Nasdaq gained 2.5%. A possible peace deal could reopen the Strait of Hormuz, a key oil shipping route, pushing U.S. crude prices down 2.6% to $87.71 a barrel. High oil prices had contributed to inflation, with U.S. wholesale prices rising more than expected in May. The market also saw volatility in artificial intelligence (AI) stocks, with chipmakers like Marvell Technology soaring following mixed swings. Higher interest rates by the European Central Bank aimed to curb inflation but could slow economic growth and impact investment valuations.

Latest articles

Bradesco Shares Rise, BBDC4 and BBD ADRs Track Brazil Market Recovery

Bradesco Shares Rise, BBDC4 and BBD ADRs Track Brazil Market Recovery

11 June 2026
Bradesco’s preferred shares jumped to R$17.67 and U.S. ADRs to $3.44 with heavy volume as Brazil’s Ibovespa surged 1.71%, spotlighting the lender after reporting a 16.1% year-over-year rise in recurring net income to R$6.811 billion in 1Q26; board and executive insiders sold non-voting shares, while the controlling group’s stake remained unchanged.
Bank of Nova Scotia Hits 52-Week High; TSX Bounces Back

Bank of Nova Scotia Hits 52-Week High; TSX Bounces Back

11 June 2026
Bank of Nova Scotia surged to a 52-week high, closing up 1.24% at C$115.27 in Toronto after announcing expanded AI adoption across its workforce and higher Q2 earnings, while the S&P/TSX Composite jumped 1.5% as financials rallied and trading volume soared above average.
Moderna Gains Almost 8% With Nasdaq Recovery; Cancer Vaccine Pipeline Still a Key Focus

Moderna Gains Almost 8% With Nasdaq Recovery; Cancer Vaccine Pipeline Still a Key Focus

11 June 2026
Moderna surged 7.94% to $49.64 as U.S. stocks rebounded sharply, with investors eyeing its mRNA cancer-vaccine pipeline after a UK trial authorization; Wall Street’s average analyst rating remains “Hold” with a $43.30 target, and BofA raised its price target to $34 citing norovirus prospects, while Moderna reported Q1 revenue of $389 million and a $1.3 billion net loss.
Applied Materials Stock Rises on AI Chip Demand, Wall Street Lifts Targets
Previous Story

Applied Materials Stock Rises on AI Chip Demand, Wall Street Lifts Targets

Rubico Jumps 43% on 154 Million RUBI Shares Traded After Trillium Discloses 5.4% Stake
Next Story

Rubico Jumps 43% on 154 Million RUBI Shares Traded After Trillium Discloses 5.4% Stake

Go toTop